ProtagonistTherapeutics News & Analysis
2 articles
Market Mood
Protagonist Therapeutics Director Selick Sells $2.52 Million in Shares
Selick, a director at Protagonist Therapeutics, has sold shares worth $2.52 million. This sale may influence investor sentiment and market perceptions of the company's future performance. Such insider selling can be interpreted as a signal concerning the company's direction and financial health. As of October 2023, details on the number of shares sold and the price per share were not disclosed.
Read More
Protagonist Therapeutics CMO Sells $1.57 Million in Company Shares
Protagonist Therapeutics' Chief Medical Officer sold shares totaling $1.57 million. This transaction comes as the company continues its development in therapeutic treatments. The sale may raise questions about insider sentiment towards the company's future performance. Monitoring such insider trading activities can provide insights into potential market reactions and investor confidence.
Read More